AASLD PRACTICE GUIDELINES Diagnosis, Management, and Treatment of Hepatitis C: An Update Marc G. Ghany,1 Doris B. Strader,2 David L. Thomas,3 and Leonard B. Seeff4 This document has been approved by the AASLD, the Infect

First Page		Document Content
Date: 2009-08-27 14:13:42 Health HIV/AIDS Hepatitis Cytokines Hepatitis C and HIV co-infection Hepatitis C virus Hepatitis C Peginterferon alfa-2a Needlestick injury Medicine Antivirals Biology		AASLD PRACTICE GUIDELINES Diagnosis, Management, and Treatment of Hepatitis C: An Update Marc G. Ghany,1 Doris B. Strader,2 David L. Thomas,3 and Leonard B. Seeff4 This document has been approved by the AASLD, the Infect Add to Reading List Source URL: www.aasld.org Download Document from Source Website File Size: 564,67 KB Share Document on Facebook

	Pegasys, INN-peginterferon alfa-2a DocID: 1tovV - View Document
	Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio DocID: 1owMZ - View Document
	NIH Public Access Author Manuscript J Hepatol. Author manuscript; available in PMC 2012 July 1. NIH-PA Author Manuscript DocID: 1gmiC - View Document
	PPAfactors-associated-with-hepatitis-c-treatment-uptake--adhere DocID: 1ghUZ - View Document
	SUPPLEMENT ARTICLE Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs Geert Robaeys,1,2,3,a Jason Grebely,4,a Stefan Mauss,5 Philip Bruggmann,6 Joseph Moussalli,7,8 Andrea De DocID: 1g6DC - View Document